Tumor dormancy and frailty models: a novel approach
From MaRDI portal
Publication:5347429
DOI10.1111/BIOM.12559zbMATH Open1366.62240OpenAlexW2511024394WikidataQ40658582 ScholiaQ40658582MaRDI QIDQ5347429FDOQ5347429
Authors: Paola M. V. Rancoita, Morten Valberg, Romano Demicheli, Elia Biganzoli, Clelia Di Serio
Publication date: 23 May 2017
Published in: Biometrics (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1111/biom.12559
Recommendations
- Mathematical Modelling of Tumour Dormancy
- A quantitative insight into metastatic relapse of breast cancer
- Generalized frailty models for analysis of recurrent events
- A parametric regression model of tumor recurrence: An application to the analysis of clinical data on breast cancer
- Frailty models based on Lévy processes
Reliability and life testing (62N05) Applications of statistics to biology and medical sciences; meta analysis (62P10)
Cites Work
- The Identifiability of the Proportional Hazard Model
- True and Spurious Duration Dependence: The Identifiability of the Proportional Hazard Model
- An extension of Gompertzian growth dynamics: Weibull and Fréchet models
- Maximum penalized likelihood estimation in a Gamma-frailty model
- Predicting survival using disease history: a model combining relative survival and frailty
- Joint modelling of cause-specific hazard functions with cubic splines: an application to a large series of breast cancer patients
Cited In (2)
This page was built for publication: Tumor dormancy and frailty models: a novel approach
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q5347429)